The role of the microbiological laboratory in diagnosing the resistance of microorgan-isms to antimicrobials: literature review

Sammendrag

Introduction. The microbiology laboratory plays a fundamental role in the proper management of patients with infectious diseases. Strengthening the capacity of microbiological diagnosis is justified by its essential role in the diagnosis of specific infectious diseases and the establishment of targeted antimicrobial therapy.

The aim. A literature analysis on the role of the microbiological laboratory in the diagnosis of antimicrobial resistance (AMR).

Material and methods. To conduct the study, PubMed, WHO, and ECDC were researched using keywords such as AMR, microbiological diagnosis, and antimicrobial stewardship. We identified and analysed 89 relevant publications from a pool of 235 studied sources.

Results. To enhance the microbiological diagnostic capacity for antimicrobial resistance, a series of actions are necessary. Firstly, the legislative framework governing the organization and operation of laboratories needs elaboration. Currently, a national level working group is being established to formulate these regulations. This document will be tailored to the requirements of the health system and technological advancements, emphasizing swift diagnostic methods for guiding antimicrobial therapy. An essential intervention involves encouraging microbiologists to actively participate in managing infections in hospitalized patients as part of multidisciplinary teams, with a pivotal role in deciding antimicrobial therapy. International evidence highlights the significance of equipping laboratories with modern technology and updating guidelines and protocols to align with European standards. These actions have a direct impact on patient care and outcomes, influencing therapeutic decisions, controlling healthcare-associated infections, reducing hospital stays, and minimizing overall hospital costs. This, in turn, directly affects judicious antimicrobial prescribing efforts. Programs for the correct use of antimicrobial treatments should encompass activities ensuring the precise selection of an antibiotic regimen, daily dose, route of administration, interval between doses, and the duration of therapy. The goal is to achieve maximum clinical benefit in preventing or treating infections while minimizing adverse effects, toxicity, and the risk of selecting and promoting antibiotic resistance.

Conclusions. Microbiology laboratories play a crucial role in detecting the etiological agent, standing at the forefront of identifying events with infectious origins. Testing should be conducted in laboratories equipped with state-of-the-art facilities and staffed by qualified personnel.

Note: This paper has been written within the framework of the project: 20.80009.8007.09 "Studying the mechanisms of antimicrobial resistance in gram-negative bacilli in order to strengthen the national surveillance system"

pdf (English)

|Utsikt: 117| |pdf (English) Nedlastinger: 40|


pdf (English)
##submission.license.cc.by4.footer##

##plugins.generic.usageStats.downloads##

##plugins.generic.usageStats.noStats##

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370